Gefitinib, CAS 184475-35-2 Sole GMP Manufacturer
Gefitinib, CAS 184475-35-2 stable novel crystalline or amorphous form both we have, Gefitinib, CAS 184475-35-2no any IP problem. Gefitinib, CAS 184475-35-2 DMF filling, free sample of Gefitinib, CAS 184475-35-2.
EOS Med Chem have already carried out Gefitinib, CAS 184475-35-2 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Gefitinib, CAS 184475-35-2 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Gefitinib, CAS 184475-35-2 Intermeidates list, most from GMP plant:
Gefitinib, CAS 184475-35-2 HNMR, MASS, COA, MSDS we have.
Gefitinib, CAS 184475-35-2, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Gefitinib, CAS 184475-35-2 stable novel crystalline or amorphous form both we have, Gefitinib, CAS 184475-35-2no any IP problem. Gefitinib, CAS 184475-35-2 DMF filling, free sample of Gefitinib, CAS 184475-35-2.
EOS Med Chem have already carried out Gefitinib, CAS 184475-35-2 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Gefitinib, CAS 184475-35-2 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Gefitinib, CAS 184475-35-2 Intermeidates list, most from GMP plant:
| Gefitinib, CAS 184475-35-2 Intermediate 621-59-0, stock 1.5kg, assay 98.5%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 52805-46-6, stock 7.9kg, assay 98.5%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 675126-28-0, stock 6kg, assay 98.8%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 675126-27-9, stock 4.5kg, assay 98.8%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 246512-44-7, stock 1.7kg, assay 98.4%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 199327-59-8, stock 5.8kg, assay 98.8%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 367-21-5, stock 8.6kg, assay 98.7%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 179688-52-9, stock 6.6kg, assay 99%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 179688-54-1, stock 3.9kg, assay 98.5%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 184475-71-6, stock 3.7kg, assay 98.8%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 727658-04-0, stock 7.1kg, assay 98.5%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 93-07-2, stock 6.5kg, assay 98.5%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 4998-07-6, stock 2.4kg, assay 98.7%, White powder. |
| Gefitinib, CAS 184475-35-2 Intermediate 31839-21-1, stock 4.7kg, assay 98.7%, White powder. |
| Gefitinib, Intermediate 179688-53-0, stock 7.2kg, assay 98.8%, White powder. |
| Gefitinib, Intermediate 184475-35-2, stock 6.8kg, assay 98.2%, White powder. |
| Gefitinib, Intermediate 184475-70-5, stock 4kg, assay 98.5%, White powder. |
| Gefitinib, Intermediate 199327-61-2, stock 6kg, assay 98.2%, White powder. |
| Gefitinib, Intermediate 31839-20-0, stock 4.3kg, assay 98.5%, White powder. |
| Gefitinib, Intermediate 7357-67-7, stock 3.6kg, assay 98.6%, White powder. |
| Gefitinib, Intermediate 788136-89-0, stock 1.4kg, assay 98.6%, White powder. |
Gefitinib, CAS 184475-35-2 HNMR, MASS, COA, MSDS we have.
Gefitinib, CAS 184475-35-2, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
